PTGX earnings: a positive outcome, +8.6%

On November 7, 2017, Protagonist Therapeutics, Inc reached its earnings. The result was a positive outcome, and the stock moved +8.6% in the window around the event. It had already run -21.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.